Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study Evaluating the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection
Sponsor: Hunan Kelun Pharmaceutical Co., Ltd.
Summary
To evaluate the pharmacokinetic interaction of KL0011034 injection in combination with alfentanil hydrochloride injection.To evaluate the safety and tolerability of KL0011034 injection in combination with alfentanil hydrochloride injection.To evaluate the effect of alfentanil hydrochloride injection on the pharmacodynamics of KL0011034 injection.
Official title: A Single-Center, Randomized, Open-Label, Three-Sequence, Three-Period Crossover Study to Evaluate the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
27
Start Date
2026-07-15
Completion Date
2026-08-12
Last Updated
2026-09-17
Healthy Volunteers
No
Conditions
Interventions
KL0011034 injection
Intravenous injection, single dose
Alfentanil Hydrochloride Injection
Intravenous injection, single dose
Locations (1)
The Third XIANGYA Hospital of Central South University
Changsha, Hunan, China